- Home
- LH
as 07-26-2024 4:00pm EST
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Upcoming Earnings Alert:
Get ready for potential market movements as Laboratory Corporation of America Holdings LH prepares to release earnings report on 01 Aug 2024.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 17.4B | IPO Year: | N/A |
| Target Price: | $241.46 | AVG Volume (30 days): | 505.1K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.06 | EPS Growth: | -54.46 |
| 52 Week Low/High: | $191.97 - $234.09 | Next Earning Date: | 08-01-2024 |
| Revenue: | $12,300,400,000 | Revenue Growth: | 4.62% |
| Revenue Growth (this year): | 8.67% | Revenue Growth (next year): | -0.03% |
Stock Insider Trading Activity of Laboratory Corporation of America Holdings (LH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ANDERSON KERRII B | LH | Director | Apr 30 '24 | Sell | $204.14 | 250 | $51,033.75 | 15,972 | SEC Form 4 |
| ANDERSON KERRII B | LH | Director | Apr 30 '24 | Sell | $200.10 | 250 | $50,024.52 | 15,722 | SEC Form 4 |
| Summy Amy B. | LH | EVP, Chief Marketing Officer | Apr 1 '24 | Sell | $217.29 | 3,500 | $760,515.00 | 3,975 | SEC Form 4 |
| Summy Amy B. | LH | EVP, Chief Marketing Officer | Mar 7 '24 | Sell | $218.45 | 227 | $49,588.15 | 3,859 | SEC Form 4 |
| EISENBERG GLENN A | LH | Chief Financial Officer, EVP | Feb 21 '24 | Sell | $215.37 | 18,379 | $3,958,213.55 | 39,720 | SEC Form 4 |
| EISENBERG GLENN A | LH | Chief Financial Officer, EVP | Feb 21 '24 | Sell | $215.68 | 7,907 | $1,705,349.34 | 31,813 | SEC Form 4 |
| EISENBERG GLENN A | LH | Chief Financial Officer, EVP | Feb 21 '24 | Sell | $217.52 | 6,665 | $1,449,774.13 | 25,148 | SEC Form 4 |
| EISENBERG GLENN A | LH | Chief Financial Officer, EVP | Feb 21 '24 | Sell | $217.98 | 1,553 | $338,529.46 | 23,595 | SEC Form 4 |
Latest Laboratory Corporation of America Holdings News
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
PR Newswire
2 days ago
Labcorp Declares Quarterly Dividend
Zacks
4 days ago
Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release
Simply Wall St.
9 days ago
Can Mixed Financials Have A Negative Impact on Labcorp Holdings Inc.'s 's (NYSE:LH) Current Price Momentum?
Zacks
9 days ago
Strength Seen in Henry Schein (HSIC): Can Its 5.4% Jump Turn into More Strength?
MT Newswires
11 days ago
UBS Cuts Laboratory Corp of America Price Target to $260 From $262, Maintains Buy Rating
Zacks
15 days ago
Implied Volatility Surging for Labcorp (LH) Stock Options
Zacks
15 days ago
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Compare LH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.